Amalgamated Bank’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,687
Closed -$15K 2019
2025
Q4
$15K Sell
3,687
-273
-7% -$1.52K ﹤0.01% 2238
2025
Q3
$34K Hold
3,960
﹤0.01% 1950
2025
Q2
$45K Hold
3,960
﹤0.01% 1850
2025
Q1
$38K Buy
3,960
+14
+0.4% +$141 ﹤0.01% 1859
2024
Q4
$44K Hold
3,946
﹤0.01% 1865
2024
Q3
$112K Hold
3,946
﹤0.01% 1692
2024
Q2
$75K Buy
3,946
+193
+5% +$4.93K ﹤0.01% 1772
2024
Q1
$123K Sell
3,753
-12,153
-76% -$388K ﹤0.01% 1689
2023
Q4
$525K Sell
15,906
-1,117
-7% -$31.6K ﹤0.01% 1426
2023
Q3
$464K Buy
17,023
+1,500
+10% +$41.7K ﹤0.01% 1455
2023
Q2
$470K Buy
15,523
+3,902
+34% +$126K ﹤0.01% 1468
2023
Q1
$377K Sell
11,621
-1,877
-14% -$59.4K ﹤0.01% 1548
2022
Q4
$379K Buy
13,498
+305
+2% +$8.74K ﹤0.01% 1590
2022
Q3
$474K Buy
13,193
+212
+2% +$7.47K ﹤0.01% 1460
2022
Q2
$399K Buy
12,981
+2,683
+26% +$78.2K ﹤0.01% 1569
2022
Q1
$333K Sell
10,298
-660
-6% -$17.3K ﹤0.01% 1722
2021
Q4
$303K Buy
10,958
+34
+0.3% +$975 ﹤0.01% 1810
2021
Q3
$339K Sell
10,924
-717
-6% -$17.2K ﹤0.01% 1789
2021
Q2
$246K Buy
+11,641
New +$233K ﹤0.01% 1960
2020
Q2
Sell
-11,636
Closed -$63K 1528
2020
Q1
$63K Sell
11,636
-176
-1% -$1.57K ﹤0.01% 1546
2019
Q4
$107K Buy
11,812
+965
+9% +$7.84K ﹤0.01% 1726
2019
Q3
$78K Sell
10,847
-102
-0.9% -$732 ﹤0.01% 1675
2019
Q2
$87K Buy
+10,949
New +$130K ﹤0.01% 1700
2018
Q4
Sell
-7,924
Closed -$225K 1641
2018
Q3
$225K Buy
+7,924
New +$189K 0.01% 1263

Other funds holding EVH

Amalgamated Bank's EVH Position: Q1 2026 in Review

Amalgamated Bank sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 3,687 shares — an estimated $15K sold.

Amalgamated Bank first reported a position in EVH in Q3 2018 and held it in 24 quarters. The position peaked at $525K in Q4 2023. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Amalgamated Bank reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 3,687 Evolent Health shares in Q1 2026, an estimated $15K.
  • Amalgamated Bank first reported a position in Evolent Health in Q3 2018 and held it in 24 quarters.
  • Amalgamated Bank's Evolent Health position peaked at $525K in Q4 2023.
  • 192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.